Gut-Brain Axis (장뇌축) — 2026-04-24

🔬 Research Highlights

Coffee shifts the microbiome to influence mood and stress

• Research Team: APC Microbiome Ireland, University College Cork
• Key Findings: Clinical trials confirm that regular coffee consumption alters the gut microbiome and influences mood and stress levels, regardless of caffeine content. Similar effects were observed with decaffeinated coffee, suggesting that coffee’s brain-health benefits stem from bioactive compounds other than caffeine.
• Significance: This is the first large-scale clinical evidence identifying the specific mechanism by which coffee acts on mental health via the gut-brain axis, providing a foundation for future diet-based mental health interventions.

Extra virgin olive oil enhances gut diversity and cognitive function

• Research Team: ScienceDaily report, 2-year follow-up clinical study
• Key Findings: A two-year study found that the group consuming extra virgin olive oil showed higher cognitive performance and more diverse gut bacterial compositions compared to the refined olive oil group. This suggests that the brain-protective effects of olive oil may be mediated through changes in the gut microbiome.
• Significance: By directly measuring the impact of dietary fat types on the gut-brain axis, this result strengthens the mechanistic evidence for the cognitive-protective effects of the Mediterranean diet.

Parkinson’s risk: Predicting symptoms years in advance via gut microbes

• Research Team: Multiple research institutions (Euronews report, April 21, 2026)
• Key Findings: Specific patterns in gut bacteria have been found to identify at-risk groups years before Parkinson’s symptoms emerge. These microbial changes were particularly pronounced in individuals carrying genetic risk factors for Parkinson’s.
• Significance: This suggests that gut microbiome analysis could serve as a biomarker for early diagnosis, opening new avenues for preventive strategies and early intervention in neurodegenerative diseases.

2 sources

euronews.com

euronews.com

euronews.com

euronews.com

💊 Clinical Trials & Therapeutic Trends

• Seres Therapeutics SER-155: Seres Therapeutics presented updated data on SER-155 at ESCMID Global 2026. Key findings highlighted sustained modulation of the gut microbiome and improved intestinal epithelial barrier integrity post-administration. Discussions also covered the role of live biotherapeutics in clinical outcomes for IBD and immunocompromised patients.

• Human trials on symbiotics/psychobiotics: A recent review (March 2026) in Frontiers in Microbiology highlights that the mental health benefits of psychobiotics via the gut-brain axis are being confirmed in multiple human clinical trials, with the regulation of neurotransmitters (serotonin, GABA) and immune pathways identified as primary mechanisms.

🏢 Industry & Business

• Pendulum enters nationwide Sprouts Farmers Market: Microbiome brand Pendulum has launched its products—including Metabolic Daily, Akkermansia, and Glucose Control GLP-1 Probiotic—in Sprouts Farmers Market stores across the country. The microbiome therapeutic market is expected to grow from $57.4 million in 2026 to $310.6 million by 2033 (CAGR 27.3%).

• Microbiome Labs relaunches BiomeFX: Microbiome Labs has relaunched its BiomeFX service, revealing an upgraded platform designed to increase the precision of gut microbial interpretation and enable researchers and clinicians to utilize more meaningful microbiome data.

🧠 Deep Dive: Coffee and the gut-brain axis — A pathway that works without caffeine

The clinical findings from APC Microbiome Ireland mark an interesting turning point in coffee-gut-brain research. Previously, the mood-enhancing effects of coffee were primarily attributed to caffeine’s ability to block adenosine receptors. However, the fact that decaffeinated coffee induced similar changes in the gut microbiome and improved mood and stress levels suggests that coffee’s polyphenols (like chlorogenic acid) and dietary fiber promote the growth of beneficial bacteria. These bacteria likely produce short-chain fatty acids (SCFAs), which send signals to the brain through the gut-vagus nerve-brain pathway. SCFAs are known to stimulate the vagus nerve or cross the blood-brain barrier to regulate inflammation and provide neuroprotection. The remaining questions are which specific coffee compounds trigger which strains, and whether these effects are sustained long-term. Individual baseline microbiome composition will also remain a key variable for future precision nutrition research.

📋 Action Guide

1. Include extra virgin olive oil in your daily diet: A two-year study shows that it outperforms refined olive oil in increasing microbial diversity and improving cognitive function. Try using 1–2 tablespoons in salads or cooking.
2. You don't need caffeine to reap the gut-brain benefits of coffee: Decaffeinated coffee shows similar efficacy in altering the microbiome and improving mood. If you are sensitive to caffeine, you can still enjoy the gut health perks.
3. Diversify dietary fiber for microbiome variety: Mediterranean-style patterns (whole grains, vegetables, legumes, nuts) have the strongest evidence for gut-brain health. Pairing various vegetables with fermented foods (kimchi, soybean paste, yogurt) effectively boosts microbial diversity.
4. If you have a family history of Parkinson’s, focus on gut health: While not yet a commercial diagnostic tool, recent research shows that specific microbial patterns can appear years before symptoms. Managing gut health through diet may become a potential strategy for preventing neurodegeneration.

👀 Key Points to Watch

• Microbiome therapeutic market growth: The market is expected to grow at a CAGR of 27.3% between 2026 and 2033, with intense competition in live biotherapeutics, postbiotics, and genetically engineered strains beyond standard FMT. FDA application filings are expected to rise within the next 2–3 years.
• Microplastics and the microbiome: New research into how microplastics interact with gut bacteria to affect health is gaining attention, positioning the link between environmental pollution and the gut-brain axis as a new field of study.
• Precision Psychobiotics: With advancements in strain-specific mechanism identification and metabolic profiling, the development of psychobiotics optimized for an individual's specific gut composition is accelerating. Regulatory approval pathways for mental health indications like depression and anxiety are expected to open as more clinical data accumulates.